MYB and acute myeloid leukemia: Suppression of MYB mRNA by miR-107 revealed a possible mechanism of acute myeloid leukemia (AML) resistance to the antileukemic nucleoside cytarabine in AML cell lines and patient samples, which indicates a tumor suppressor role of MYB in the interplay with miR-107[73].